Abdominal Pain in Oncology

Marion Debus

Last update: 12.06.2019

Abdominal pain in the context of tumor disease can have many different causes. For a general description of the understanding of pain and the various options for treating it, please refer to the corresponding chapter in “Internal Medicine” by Matthias Girke (1, p. 821 ff) and to the Vademecum of Anthroposophic Medicines (2).

The various pain qualities – cramping, burning, piercing or colicky pain – are characterized by the soul body intervening too strongly and holding fast in different ways, resulting in a pathological process of consciousness in the diseased organs which is experienced as pain. This pathological intervention of the soul body can be relieved or diverted with appropriate plant, mineral or organ preparations, as well as with external applications and certain qualities of touch in rhythmical massage therapy. It is not uncommon for such interventions to result in a significant reduction in or even complete discontinuation of the use of conventional painkillers.

Bibliography

  1. Girke M. Internal medicine. Foundations and therapeutic concepts of Anthroposophic Medicine. 1st ed. Berlin: Salumed; 2016.
  2. Association of Anthroposophic Physicians in Germany, Medical Section at the Goetheanum (eds.). Vademecum of anthropsophic medicines. 3rd English ed. Munich; 2017. www.vademecum.org

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine